Among ESCC samples, somatic mutations in NFE2L2 were the second most frequently detected (16/44, 36.4%) after TP53 mutations, but no NFE2L2 mutations were detected in EAC cases. Here, TP53 is linked to esophageal squamous cell carcinoma.